IRIS UniCatt

Macchia, Gabriella
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 6.871
NA - Nord America 5.985
AS - Asia 2.723
SA - Sud America 437
AF - Africa 95
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 11
Totale 16.136
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.877
DE - Germania 2.754
SE - Svezia 1.307
SG - Singapore 969
CN - Cina 949
IT - Italia 614
UA - Ucraina 549
BR - Brasile 406
FR - Francia 322
IE - Irlanda 316
GB - Regno Unito 263
IN - India 253
FI - Finlandia 197
ID - Indonesia 190
PL - Polonia 155
RU - Federazione Russa 115
TR - Turchia 106
CA - Canada 84
BE - Belgio 53
CI - Costa d'Avorio 53
NL - Olanda 47
CZ - Repubblica Ceca 41
JP - Giappone 41
HK - Hong Kong 39
IR - Iran 30
AT - Austria 29
KR - Corea 25
VN - Vietnam 22
LT - Lituania 20
ES - Italia 14
EG - Egitto 12
AE - Emirati Arabi Uniti 11
EU - Europa 11
MX - Messico 10
AR - Argentina 9
CH - Svizzera 9
PH - Filippine 9
RO - Romania 9
AU - Australia 8
BD - Bangladesh 8
MA - Marocco 8
CL - Cile 7
GR - Grecia 7
IQ - Iraq 7
PT - Portogallo 7
ZA - Sudafrica 7
HU - Ungheria 6
IL - Israele 6
RS - Serbia 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
AM - Armenia 5
AZ - Azerbaigian 5
JM - Giamaica 5
KE - Kenya 5
LK - Sri Lanka 5
BH - Bahrain 4
CO - Colombia 4
EC - Ecuador 4
JO - Giordania 4
KZ - Kazakistan 4
LU - Lussemburgo 4
MT - Malta 4
PE - Perù 4
PK - Pakistan 4
SK - Slovacchia (Repubblica Slovacca) 4
DK - Danimarca 3
DZ - Algeria 3
HR - Croazia 3
KG - Kirghizistan 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
BG - Bulgaria 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MK - Macedonia 2
MY - Malesia 2
NP - Nepal 2
PA - Panama 2
TN - Tunisia 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AG - Antigua e Barbuda 1
AL - Albania 1
BZ - Belize 1
CM - Camerun 1
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
KW - Kuwait 1
MD - Moldavia 1
MU - Mauritius 1
NI - Nicaragua 1
OM - Oman 1
QA - Qatar 1
SI - Slovenia 1
SN - Senegal 1
Totale 16.130
Salva come PNG Salva come JPEG
Città #
Chandler 1.363
Singapore 575
Ashburn 451
Jacksonville 321
Dublin 313
San Mateo 260
Nanjing 199
Jakarta 188
Wilmington 181
Dearborn 165
Warsaw 149
New York 140
Nürnberg 140
The Dalles 139
Milan 134
Boston 125
Bremen 123
Woodbridge 115
Marseille 112
Ann Arbor 106
Hyderabad 102
Beijing 101
Izmir 88
Helsinki 85
Lawrence 85
Cattolica 84
Rome 84
Los Angeles 83
Houston 79
Princeton 79
Fairfield 76
Moscow 76
Nanchang 76
Munich 71
Seattle 58
Redwood City 56
Abidjan 53
Brussels 53
Frankfurt am Main 44
São Paulo 44
Leawood 40
Hefei 38
Toronto 37
Zhengzhou 37
Düsseldorf 36
University Park 36
Shenyang 34
Hebei 32
Kunming 32
Phoenixville 32
Augusta 29
Fremont 29
Boardman 28
Tianjin 28
Changsha 27
Hong Kong 27
Jiaxing 26
Lancaster 26
Cambridge 25
Falls Church 25
Mountain View 25
Seoul 25
Norwalk 23
London 22
Pune 22
Shanghai 22
Detroit 21
North York 21
Auburn Hills 20
Brno 19
Guangzhou 19
Hangzhou 19
Redmond 18
Lauterbourg 17
Nuremberg 17
Vienna 17
Chicago 16
Amsterdam 15
San Francisco 15
Falkenstein 14
Hanoi 14
Lanzhou 13
Monmouth Junction 13
Washington 13
Portsmouth 12
Stockholm 12
Tokyo 12
Ottawa 11
Phoenix 11
Andover 10
Ardabil 10
Rio de Janeiro 10
Cairo 9
Edinburgh 9
Goiânia 9
Montreal 9
Santa Clara 9
Belo Horizonte 8
Berlin 8
Brooklyn 8
Totale 7.997
Salva come PNG Salva come JPEG
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 808
Results of a phase II study of Short-course Accelerated Radiation Therapy (SHARON) for multiple brain metastases 260
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 181
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 173
Volumetric modulated arc therapy with simultaneous integrated boost for locally advanced rectal cancer 158
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 157
Chemoradiation and brachytherapy in biliary tract carcinoma - Long-term results 155
Chemoradiation and brachytherapy in extrahepatic bile duct carcinoma 151
Planning comparison between standard and conformal 3D techniques in post-operative radiotherapy of gastric cancer: a systematic review 150
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 148
Radioprotective effect of moderate wine consumption in patients with breast carcinoma. 146
Capecitabine based postoperative accelerated chemoradiation of pancreatic carcinoma. A dose-escalation study. 145
Long-term Analysis of Gemcitabine-based Chemoradiation after Surgical Resection for Pancreatic Adenocarcinoma 145
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 145
Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report 144
Phase I-II studies on accelerated IMRT in breast carcinoma: technical comparison and acute toxicity in 332 patients. 141
Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma 141
A systematic review of resectability and survival after concurrent chemoradiation in primarily unresectable pancreatic cancer. 140
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 140
Clinical target volume delineation including elective nodal irradiation in preoperative and definitive radiotherapy of pancreatic cancer 140
Intensity-modulated radiotherapy with simultaneous integrated boost to dominant intraprostatic lesion: preliminary report on toxicity 140
Intraluminal brachytherapy without stenting in intrahepatic papillary cholangiocarcinoma: a case report 138
Postoperative intensity modulated radiation therapy in high risk prostate cancer: A dosimetric comparison. 138
Applicator-guided volumetric-modulated arc therapy for low-risk endometrial cancer 136
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 135
Quality of life and toxicity of stereotactic radiotherapy in pancreatic tumors: a case series 133
Accelerated intensity-modulated radiotherapy plus temozolomide in patients with glioblastoma: a phase I dose-escalation study (ISIDE-BT-1) 133
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 133
Early radiation-induced mucosal changes evaluated by proctoscopy: Predictive role of dosimetric parameters 132
Endocavitary in vivo dosimetry for IMRT treatments of gynecologic tumors 131
A phase I study of short-course accelerated whole brain radiation therapy for multiple brain metastases 130
Preoperative Chemoradiation With VMAT-SIB in Rectal Cancer: A Phase II Study 126
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 125
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 125
Concomitant boost radiotherapy and multidrug chemotherapy in the neoadjuvant treatment of locally advanced rectal cancer: results of a phase II study 124
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 124
Early proctoscopy is a surrogate endpoint of late rectal toxicity in prostate cancer treated with radiotherapy 123
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 123
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: preliminary results of a phase II trial 122
Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience 122
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 121
FOLFIRI-bevacizumab and concurrent low-dose radiotherapy in metastatic colorectal cancer: preliminary results of a phase I-II study 121
Incidence and management of noncancer pain in cancer patients referred to a radiotherapy center 120
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 119
Eccrine Syringofibroadenoma radiation treatment of an unusual presentation 119
Radiotherapy and concurrent metronomic chemotherapy in hormone-refractory prostate carcinoma: a Phase I study 118
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 115
In Vivo Portal Dosimetry by an Ionization Chamber 115
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 114
Forward-planned intensity modulated radiation therapy using a cobalt source: A dosimetric study in breast cancer 112
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 110
Short-course radiotherapy in elderly patients with early stage non-melanoma skin cancer: a phase II study 109
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 108
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 108
Intraoperative radiation therapy in resected pancreatic carcinoma: long-term analysis. 107
An in-vivo dosimetry procedure for Elekta step and shoot IMRT 107
Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases 107
Radiochemotherapy with Gemcitabine in Unresectable Extrahepatic Cholangiocarcinoma: Long-term Results of a Phase II Study 106
Postoperative intensity modulated radiation therapy in high risk prostate cancer: a dosimetric comparison 105
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 104
Postoperative intensity-modulated radiotherapy with simultaneous integrated boost in prostate cancer: A dose-escalation trial 103
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 103
Radioprotective effect of calcium channel blockers against late rectal bleeding in prostate cancer 103
A phase I dose-escalation study (iside-bt-1) of accelerated imrt with temozolomide in patients with glioblastoma. 102
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 100
Real time transit dosimetry for the breath-hold radiotherapy technique experience 99
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 98
Initial clinical experience with Epid-based in-vivo dosimetry for VMAT treatments of head-and-neck tumors 98
Neoadjuvant Accelerated Concomitant Boost Radiotherapy and Multidrug Chemotherapy in Locally Advanced Rectal Cancer: A Dose-Escalation Study 97
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 96
Hypofractionated intensity-modulated radiotherapy with simultaneous integrated boost after radical prostatectomy: Preliminary results of a phase II trial 96
Management of oligometastatic ovarian cancer recurrence during PARP inhibitor maintenance 95
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 94
Synchronous male carcinoma of the breast, exocrine pancreas, and prostate 94
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 93
Palliative short-course radiation therapy in rectal cancer: A phase 2 study 93
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 92
Palliative two-dimensional radiotherapy of pancreatic carcinoma: a feasibility study. 92
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 91
Complexity index (COMIX) and not type of treatment predicts undetected errors in radiotherapy planning and delivery. 89
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 88
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 88
Feasibility Study Of Moderately Accelerated Intensity-Modulated Radiotherapy Plus Concurrent Weekly Cisplatin After Induction Chemotherapy In Locally Advanced Head-And Neck Cancer. 87
Concurrent Chemoradiation with Concomitant Boost in Locally Advanced Rectal Cancer: A Phase II Study 87
Underuse of brachytherapy for the treatment of dysphagia owing to esophageal cancer. An Italian survey 87
Linac-based extracranial radiosurgery with Elekta volumetric modulated arc therapy and an anatomy-based treatment planning system: Feasibility and initial experience 86
Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost in Patients With Brain Oligometastases: A Phase 1 Study (ISIDE-BM-1) 85
Optimal beam margins in linac-based VMAT stereotactic ablative body radiotherapy: A Pareto front analysis for liver metastases 84
Postoperative treatment of intermediate-risk early stage cervical cancer: results of a survey from the Gynecology Study Group in the AIRO Gyn and MITO Groups 84
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 83
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 80
18 F-FDG Pet-Guided External Beam Radiotherapy in Iodine-Refractory Differentiated Thyroid Cancer: A Pilot Study 80
Progestin-releasing intrauterine device insertion plus palliative radiotherapy in frail, elderly uterine cancer patients unfit for radical treatment 79
Cervical cancer patterns of care in Italy: A radiation oncology survey of MITO and AIRO GYN groups 79
Completion surgery after concomitant chemoradiation in locally advanced cervical cancer: a comprehensive analysis of pattern of postoperative complications 78
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 77
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 76
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 75
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 75
Efficacy and safety of stereotactic body radiotherapy (SBRT) in oligometastatic/persistent/recurrent ovarian cancer: a prospective, multicenter phase II study (MITO-RT3/RAD) 75
Totale 12.167
Salva come PNG Salva come JPEG
Categoria #
all - tutte 71.991
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.991
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020363 0 0 0 0 0 0 0 0 0 0 228 135
2020/20211.214 64 141 24 136 161 48 128 31 129 98 197 57
2021/20221.580 153 107 15 107 111 57 23 216 62 111 308 310
2022/20233.828 521 539 262 610 263 423 223 292 419 79 148 49
2023/20241.701 66 484 75 129 52 215 101 131 20 52 237 139
2024/20253.074 106 84 240 136 419 103 97 175 600 446 668 0
Totale 16.805